🇺🇸 FDA
Patent

US 8986695

Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5

granted A61KA61K38/47A61K38/4813

Quick answer

US patent 8986695 (Enhanced staphylolytic activity of the Staphylococcus aureus bacteriophage vB—SauS-philPLA88 virion-associated peptidoglycan hydrolase HydH5: fusions, deletions and synergy with LysH5) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K38/47, A61K38/4813, A61K38/4886, A61K38/54